Inappropriate ADH Syndrome - 16 Studies Found
Completed |
: Safety and Efficacy of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion :
: 2005-12-12 : Drug: SR121463B |
Completed |
: Efficacy and Safety of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion :
: 2005-12-12 : Drug: SR121463B |
Completed |
: Effects of Empagliflozin an SGLT2-Inhibitor on Healthy Volunteers With Induced Hypotonic Hyponatremia - the DIVE Study : Inappropriate ADH Syndrome : 2016-03-24 :
|
Withdrawn |
: Urinary Aquaporine 2 in Patients With Syndrome of Inappropriate ADH-secretion Caused by Treatment With Antiepileptic Medicine : Syndrome of Inappropriate ADH-secretion : 2006-03-01 : Procedure: fluid restriction for 14 days (15ml fluid per kg weight) |
Terminated |
: A Phase III Study Evaluating the Efficacy and Safety of Satavaptan Versus Placebo in Patients With Dilutional Hyponatremia :
: 2008-07-31 :
|
Completed |
: A PK Study of 3 Dosages of Tolvaptan in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) : Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) : 2013-12-09 : Drug: tolvaptan Subjects will receive a single dose of 3.75, 7.5 or 15 mg of tolvaptan on study Day 1 |
Completed |
: Efficacy of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion :
|
Recruiting |
: A Multicenter Trial to Investigate the Efficacy and Safety of Tolvaptan in Patients With Hyponatremia in SIADH : Syndrome of Inappropriate Antidiuretic Hormone Secretion : 2017-02-07 : Drug: Tolvaptan Oral Tablet Tolvaptan tablets at 7.5, 15, 30 (one tablet each), or 60 mg (two 30 mg tabl |
Terminated |
: Effects of Tolvaptan vs Fluid Restriction in Hospitalized Subjects With Dilutional Hyponatremia :
|
Completed |
: An Observational Study to Describe the Adherence to the SEOM Algorithm for the Treatment of Hyponatraemia in Spain :
|